Matthias Stein-Gerlach

Title: Matthias Stein-Gerlach: Innovator in Cellular Kinase Research

Introduction

Matthias Stein-Gerlach is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of cellular biology, particularly in understanding the mechanisms of Human Cytomegalovirus (HCMV) infection. His innovative work has implications for therapeutic development against viral infections.

Latest Patents

Stein-Gerlach holds a patent titled "Cellular kinases involved in Cytomegalovirus infection and their inhibition." This patent discloses the role of specific cellular kinases that are active during HCMV infection. These kinases are crucial for detecting HCMV infection and can be utilized to screen for inhibitors that target these cellular components. The inhibitors that effectively downregulate these key cellular kinases serve as promising therapeutics against HCMV infection. He has 1 patent to his name.

Career Highlights

Matthias Stein-Gerlach is associated with Axxima Pharmaceuticals AG, where he continues to advance research in the field of virology and cellular mechanisms. His work is pivotal in developing strategies to combat viral infections, particularly those caused by HCMV.

Collaborations

Stein-Gerlach collaborates with notable colleagues, including Daniel Schubart and Peter Habenberger. Their combined expertise enhances the research efforts at Axxima Pharmaceuticals AG, fostering innovation in therapeutic solutions.

Conclusion

Matthias Stein-Gerlach is a key figure in the study of cellular kinases and their role in HCMV infection. His patent and ongoing research contribute significantly to the development of effective treatments for viral infections.